Kite Pharma, Inc. is a privately held development stage biotechnology company engaged in the development of novel cancer immunotherapeutic products, with focus on engineered autologous T cell therapeutics targeted to different tumor types.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 05/16/13 | $20,000,000 |
Alta Partners Arie Belldegrun Commercial Street Capital David Bonderman Michael Milken Pontifax | undisclosed | |
| 04/29/14 | $50,000,000 | Mezzanine |
